Eversept Partners as of June 30, 2021
Portfolio Holdings for Eversept Partners
Eversept Partners holds 80 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 7.1 | $107M | 250k | 428.06 | |
Ark Etf Tr Genomic Rev Etf (ARKG) | 6.0 | $90M | 973k | 92.50 | |
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 5.9 | $89M | 250k | 354.43 | |
United Therapeutics Corporation (UTHR) | 5.3 | $80M | 443k | 179.41 | |
Amarin Corp Spons Adr New (AMRN) | 4.9 | $73M | 17M | 4.38 | |
Horizon Therapeutics Pub L SHS | 4.6 | $69M | 737k | 93.64 | |
Glaxosmithkline Sponsored Adr | 4.1 | $62M | 1.5M | 40.94 | |
Astrazeneca Sponsored Adr (AZN) | 3.9 | $59M | 986k | 59.90 | |
Community Health Systems (CYH) | 3.9 | $59M | 3.8M | 15.44 | |
Danaher Corporation (DHR) | 3.7 | $55M | 205k | 268.56 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.1 | $46M | 228k | 201.63 | |
Acceleron Pharma | 2.8 | $42M | 335k | 125.49 | |
Biogen Idec Call Option (BIIB) | 2.7 | $41M | 118k | 346.27 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 2.7 | $41M | 300k | 135.40 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.6 | $40M | 4.0M | 9.90 | |
Avantor (AVTR) | 2.3 | $35M | 975k | 35.51 | |
Bristol Myers Squibb (BMY) | 2.1 | $32M | 478k | 66.82 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 2.1 | $32M | 242k | 131.55 | |
Qiagen Nv Shs New | 2.1 | $32M | 651k | 48.38 | |
Fate Therapeutics (FATE) | 2.0 | $30M | 346k | 86.79 | |
Ortho Clinical Diagnostics H Ord Shs | 2.0 | $30M | 1.4M | 21.41 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.9 | $29M | 5.6M | 5.12 | |
Envista Hldgs Corp (NVST) | 1.9 | $28M | 656k | 43.21 | |
Organon & Co Common Stock (OGN) | 1.4 | $21M | 700k | 30.26 | |
Ionis Pharmaceuticals (IONS) | 1.2 | $18M | 442k | 39.89 | |
R1 Rcm | 1.1 | $17M | 770k | 22.24 | |
Healthequity (HQY) | 1.1 | $16M | 198k | 80.48 | |
AMN Healthcare Services (AMN) | 1.0 | $15M | 159k | 96.98 | |
Omnicell (OMCL) | 1.0 | $15M | 98k | 151.45 | |
McKesson Corporation (MCK) | 1.0 | $14M | 75k | 191.65 | |
Taro Pharmaceutical Inds SHS (TARO) | 0.8 | $13M | 174k | 71.96 | |
Ark Etf Tr Innovation Etf (ARKK) | 0.7 | $11M | 85k | 130.78 | |
Cigna Corp (CI) | 0.7 | $9.9M | 42k | 237.07 | |
Magellan Health Com New | 0.7 | $9.9M | 105k | 94.20 | |
Ishares Tr Tips Bd Etf Put Option (TIP) | 0.6 | $9.0M | 70k | 128.01 | |
Alnylam Pharmaceuticals (ALNY) | 0.6 | $8.7M | 51k | 169.52 | |
Zogenix Com New | 0.6 | $8.6M | 496k | 17.28 | |
Humana (HUM) | 0.6 | $8.3M | 19k | 443.40 | |
Teladoc Call Option (TDOC) | 0.4 | $6.7M | 40k | 166.29 | |
Option Care Health Com New (OPCH) | 0.4 | $6.3M | 289k | 21.87 | |
Outset Med (OM) | 0.4 | $5.4M | 107k | 49.98 | |
Centene Corporation (CNC) | 0.3 | $5.0M | 68k | 72.93 | |
Rti Biologics | 0.3 | $4.9M | 3.9M | 1.26 | |
Affimed Therapeutics B V | 0.3 | $4.8M | 567k | 8.50 | |
Intra Cellular Therapies (ITCI) | 0.3 | $4.8M | 118k | 40.82 | |
Cullinan Oncology (CGEM) | 0.3 | $4.2M | 164k | 25.75 | |
Dex (DXCM) | 0.3 | $4.1M | 9.5k | 427.00 | |
Anthem (ELV) | 0.3 | $3.9M | 10k | 381.80 | |
Merck & Co Call Option (MRK) | 0.3 | $3.8M | 49k | 77.77 | |
Kadmon Hldgs | 0.2 | $3.5M | 895k | 3.87 | |
Exelixis (EXEL) | 0.2 | $3.3M | 180k | 18.22 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $3.1M | 473k | 6.64 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.2 | $3.1M | 75k | 41.73 | |
Intersect Ent | 0.2 | $3.0M | 175k | 17.09 | |
Century Therapeutics (IPSC) | 0.2 | $3.0M | 101k | 29.34 | |
Liquidia Corporation Com New (LQDA) | 0.2 | $2.8M | 979k | 2.86 | |
Tg Therapeutics (TGTX) | 0.2 | $2.7M | 70k | 38.79 | |
Intuitive Surgical Com New (ISRG) | 0.2 | $2.4M | 2.6k | 919.64 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $2.3M | 15k | 147.81 | |
HealthStream (HSTM) | 0.1 | $2.2M | 78k | 27.94 | |
Ocular Therapeutix (OCUL) | 0.1 | $2.1M | 150k | 14.18 | |
Novavax Com New Call Option (NVAX) | 0.1 | $2.1M | 10k | 212.31 | |
Alpha Healthcare Acquistn Cl A | 0.1 | $2.1M | 205k | 10.19 | |
ACADIA Pharmaceuticals Call Option (ACAD) | 0.1 | $2.1M | 85k | 24.39 | |
Hca Holdings (HCA) | 0.1 | $1.7M | 8.3k | 206.74 | |
Seres Therapeutics (MCRB) | 0.1 | $1.4M | 60k | 23.85 | |
Global Blood Therapeutics In Put Option | 0.1 | $1.4M | 40k | 35.02 | |
Iqvia Holdings (IQV) | 0.1 | $1.4M | 5.7k | 242.32 | |
Teligent Com New (TLGTQ) | 0.1 | $1.3M | 2.5M | 0.53 | |
Immunovant (IMVT) | 0.1 | $1.2M | 110k | 10.57 | |
Natera (NTRA) | 0.1 | $1.1M | 9.3k | 113.53 | |
Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $1.1M | 229k | 4.59 | |
Frequency Therapeutics Put Option | 0.1 | $921k | 93k | 9.96 | |
F-star Therapeutics | 0.1 | $859k | 100k | 8.59 | |
Heska Corp Com Restrc New | 0.1 | $784k | 3.4k | 229.73 | |
Ensign (ENSG) | 0.1 | $778k | 9.0k | 86.72 | |
Gohealth Com Cl A | 0.1 | $772k | 69k | 11.21 | |
Repligen Corporation (RGEN) | 0.0 | $737k | 3.7k | 199.62 | |
Cross Country Healthcare (CCRN) | 0.0 | $509k | 31k | 16.51 | |
Guardant Health (GH) | 0.0 | $225k | 1.8k | 124.19 |